Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational Results available

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

ClinicalTrials.gov ID: NCT00594685

Public ClinicalTrials.gov record NCT00594685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

HIT Observational Thromboembolism Study (A TMH CTN Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Heparin-induced thrombocytopenia (HIT), a condition characterized by low platelet levels and possible blood clots, occurs in a small number of people after treatment with the drug heparin. Some people with HIT may show symptoms of a blood clot at the time of HIT diagnosis, but in another form of HIT, known as isolated HIT, people do not show blood clot symptoms even though they might have a blood clot. This study will use ultrasound tests to evaluate the presence of blood clots at the time of an HIT diagnosis and in the following month.

Study identification

NCT ID
NCT00594685
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Carelon Research
Other
Enrollment
10 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
6 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2008 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Mar 13, 2013

2008

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Emory University Atlanta Georgia 30322 —
University of Iowa Iowa City Iowa 52242 —
Tulane University New Orleans Louisiana 70112 —
University of Maryland Baltimore Maryland 21201 —
Johns Hopkins Hospital Baltimore Maryland 21205 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Children's Hospital Boston Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Minnesota Minneapolis Minnesota 55455 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Durham North Carolina 27710 —
Case Western Reserve University Cleveland Ohio 44106 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
University of Washington Seattle Washington 98104 —
Gunderson Lutheran Clinic La Crosse Wisconsin 54601 —
University of Wisconsin, Madison Madison Wisconsin 53792 —
St. Luke's Medical Center Milwaukee Wisconsin 53215 —
Froedtert Memorial Lutheran Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00594685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2013 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00594685 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →